Clinical Trial: Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
Brief Summary: The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Detailed Summary: The duration of treatment is 48 weeks.
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Tolerability
Original Primary Outcome:
Current Secondary Outcome: Plasma LDL-C, HDL-C and triglycerides after 12 weeks.
Original Secondary Outcome:
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: September 23, 2004
Date Started: April 2003
Date Completion:
Last Updated: February 24, 2017
Last Verified: February 2017